Application 210011
- Type
- ANDA
- Sponsor
- STRIDES PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALBENDAZOLE | ALBENDAZOLE | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210011-001 | ALBENDAZOLE | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | 2018-12-07 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A210011-001 | ALBENDAZOLE | 200MG | TABLET / ORAL | AB | 2018-12-07 | cb3db0bc1861… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A210011-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A210011-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A210011-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A210011-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A210011-001 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A210011-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A210011-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A210011-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A210011-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A210011-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A210011-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A210011-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A210011-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A210011-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A210011-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A210011-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A210011-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A210011-001 | AB | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A210011-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A210011-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A210011-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A210011-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A210011-001 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A210011-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A210011-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A210011-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A210011-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A210011-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A210011-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A210011-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A210011-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albendazole | ALBENDAZOLE | Edenbridge Pharmaceuticals LLC. | 6c48fd89-cb40-477c-8a78-15cbe0df6faa | 2026-07-10 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Golden State Medical Supply, Inc. | 8de337eb-92e1-15b5-e053-2a95a90ac4f1 | 2026-01-08 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Alembic Pharmaceuticals Limited | 3b4945c7-56e9-47ed-a7ac-5078a1a50b85 | 2024-09-13 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Alembic Pharmaceuticals Inc. | 2d6856a3-583e-41d4-b73d-6867cbb9778c | 2024-09-11 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Bryant Ranch Prepack | 74aeb307-b408-47b1-bd8f-fe7eeb844466 | 2024-06-28 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Dr.Reddys Laboratories Inc | 9ac95554-94c9-1f38-8f49-ec11979e4ba4 | 2020-06-10 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Novadoz Pharmaceuticals LLC | 594f7aab-b336-4d6d-b702-a33346c69645 | 2020-02-01 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Amneal Pharmaceuticals of New York LLC | 06b5eefc-0b95-4862-b9b6-770063f2adf0 | 2019-09-30 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
| ALBENZA | ALBENDAZOLE | Amneal Pharmaceuticals LLC | 1977a867-0ee1-44c0-8da3-fe59c48699f5 | 2019-09-23 | Warnings, Adverse reactions | ALBENDAZOLE |
| Albendazole | ALBENDAZOLE | Actavis Pharma, Inc. | f5c7b8cb-a81f-4b13-b3c4-f6edaf880d3b | 2019-07-31 | Warnings, Adverse reactions | Albendazole ALBENDAZOLE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 31722-935 | Albendazole | Albendazole | Camber Pharmaceuticals | ANDA | Current |
| 31722-935 | Albendazole | Albendazole | Camber Pharmaceuticals | ANDA | Current |
| 31722-935 | Albendazole | Albendazole | Camber Pharmaceuticals | ANDA | Current |
| 31722-935 | Albendazole | Albendazole | Camber Pharmaceuticals | ANDA | Current |
| 31722-935 | Albendazole | Albendazole | Camber Pharmaceuticals | ANDA | Current |
| 42291-093 | Albendazole | Albendazole | AvKARE | ANDA | Current |
| 42291-093 | Albendazole | Albendazole | AvKARE | ANDA | Current |
| 62980-513 | Albendazole | Albendazole | Vivimed Labs USA | ANDA | Current |
| 63629-1221 | Albendazole | Albendazole | Bryant Ranch Prepack | ANDA | Current |
| 63629-1221 | Albendazole | Albendazole | Bryant Ranch Prepack | ANDA | Current |
| 63629-9278 | Albendazole | Albendazole | Bryant Ranch Prepack | ANDA | Current |